Home/Filings/4/0001273636-19-000003
4//SEC Filing

Feinsod Matthew 4

Accession 0001273636-19-000003

CIK 0001273636other

Filed

Jan 14, 7:00 PM ET

Accepted

Jan 15, 7:58 PM ET

Size

6.1 KB

Accession

0001273636-19-000003

Insider Transaction Report

Form 4
Period: 2019-01-11
Feinsod Matthew
Interim Chief Medical Officer
Transactions
  • Award

    Common Stock

    2019-01-11+2,00048,791 total
  • Tax Payment

    Common Stock

    2019-01-11$3.20/sh713$2,28248,078 total
Footnotes (1)
  • [F1]The common stock vested immediately upon grant.

Issuer

APPLIED GENETIC TECHNOLOGIES CORP

CIK 0001273636

Entity typeother

Related Parties

1
  • filerCIK 0001716950

Filing Metadata

Form type
4
Filed
Jan 14, 7:00 PM ET
Accepted
Jan 15, 7:58 PM ET
Size
6.1 KB